MapLight Therapeutics, Inc. MPLT

Full chart Compare
Set alert

Price alert · MPLT

All alert types
6.81 USD +0.03 (+0.44%)

At closeNov 4, 2026, 7:38 AM EST

6.80 -0.01 -0.15%

Pre-market · Nov 4, 7:38 AM ET

6.80 Day range 7.15
6.77 52-week range 40.43
YTD
-61.24%
1 year
-59.73%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 41.50 +509.4% upside
Target (low)
30.00
Target (mean)
41.50
Target (high)
60.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy11
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 13
  • 1 month ago 12
  • 2 months ago 11
  • 3 months ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MPLT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.40-1.45 – -1.320.000.0%00.0%7
Next quarter-1.26-1.35 – -1.060.000.0%00.0%7
Current year-5.14-5.41 – -4.65-18.56+72.3%00.0%7
Next year-3.74-5.30 – -0.10-5.14+27.3%20.00M0.0%7

Upgrades and downgrades

The latest rating changes

MPLT analyst upgrades and downgrades
DateFirmActionFromTo
Jul 10, 2026NeedhamMaintainedBuyBuy
Jun 25, 2026Raymond JamesInitiated—Strong Buy
Jun 23, 2026Craig-HallumMaintainedBuyBuy
Jun 22, 2026NeedhamMaintainedBuyBuy
Jun 2, 2026StifelMaintainedBuyBuy
May 28, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 27, 2026UBSInitiated—Buy
May 21, 2026Craig-HallumInitiated—Buy
May 4, 2026HC Wainwright & Co.Initiated—Buy
Apr 8, 2026NeedhamInitiated—Buy
Apr 7, 2026TD CowenInitiated—Buy
Mar 19, 2026Canaccord GenuityInitiated—Buy
Nov 21, 2025JefferiesInitiated—Buy
Nov 21, 2025Leerink PartnersInitiated—Outperform
Nov 21, 2025StifelInitiated—Buy
Nov 21, 2025Morgan StanleyInitiated—Overweight